Click HERE to register for a LIVE presentation from industry expert Eric Langer on “Emerging Biopharma Companies Need more than Just Lab Space from Biotech Hubs”. Abstract includes:
While the lack of lab space for R&D is certainly a challenge, especially in big biotech hub cities such as San Francisco and Boston where rental is expensive, success as an emerging biopharma company extends to all aspects of business start-up. While this includes R&D space, effective incubators also provide basic operational support for startups so they can avoid hurdles to their research and data generation. Speeding R&D is an absolute requirement to attract more investment. Operational headaches can slow time-to-market; yet many of the scores of incubators and accelerators that have emerged over the past 30 years offer cheap space, and shared services. But very few also provide the operational and strategic guidance needed to help grow companies quickly. According to BioPlan’s research, what’s needed today includes broad array of ‘soft’ support services including: Training on basic equipment, advanced technology training, equipment access, staffing and recruiting for start-up companies. In fact, providing support to acquire required talent is potentially the most critical element pointing to success today. While basic, low-cost and discounted supplies, reagent and consumables can be helpful, these supports to not avoid ‘killer’ problems like the inability to find good scientists or managers, vital to growing a business. Other important areas include support for obtaining grants and funding. Commercial funding experience is something most early stage companies do not have expertise with at the senior level.
Click HERE to register.